TUMOUR IMMUNOLOGY

Predicting the anti-PD1 response

Article metrics

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

References

    Original article

    1. Chow, M. T. et al. Intratumoral activity of the CXCR3 chemokine system is required for the efficacy of anti-PD-1 therapy. Immunity https://doi.org/10.1016/j.immuni.2019.04.010 (2019)

    Download references

    Author information

    Correspondence to Kirsty Minton.

    Rights and permissions

    Reprints and Permissions

    About this article

    Verify currency and authenticity via CrossMark